Basel-based Novartis AG sold its California blood unit to Spain's Grifol's SA for USD1.68 billion.
Healthcare Health/Fitness
Top deals of the day - M&As
The following bids, mergers, acquisitions and disposals were reported on Tuesday. Top Russian oil firm Rosneft said it would sell about $6 billion worth of refined products to BP, establishing the British major among its biggest buyers after years without any such deal.
Just Retirement conducts IPO
Just Retirement is the British pension provider for retirees with health issues and has been listed in the London Stock Exchange to be valued at GBP1.1 billion on Tuesday.
Merz Pharma purchases aesthetics specialist Anteis
Merz Pharma group recently bought Geneva-based aesthetics medicine specialist Antes SA for an unconfirmed amount in a transaction that would extend its product reach to North America
Top deals of the day - mergers & acquisitions
The following bids, mergers, acquisitions and disposals were reported on Monday. The following bids, mergers, acquisitions and disposals were reported on Monday.
Latest News
Healthcare company Johnson & Johnson stopped selling some of its products to Amazon.com because of complaints about the site's third party sellers.
New Zealand healthcare company Bupa became the top operator in the region after it acquired three rest-homes in Dunedin, Gore and Riverton.
Extreme athletics showcase Nitro Circus announced it would become one with the touring company that helped produce its live programs.
Assam Chief Minister Tarun Gogoi, in a press conference, discussed the construction of a cancer and surgical cleft center in his state with the help of private entities.
Symbion, which was privatized in 2007, is preparing for its sale. Surgical facilities operator Symbion Inc, which was privatized back in 2007, is now up for sale.
The following bids, mergers, acquisitions and disposals were reported on Friday. The following bids, mergers, acquisitions and disposals were reported on Friday:- Healthcare conglomerate Danaher Corp has teamed up with Blackstone Group LP BX.
Many private equity firms and partnerships are in the process of formulating their bids for diagnostic unit of Johnson&Johnson.
The Office of Fair Trading said the joint venture between University College London Hospitals, the Royal Free London and The Doctors Laboratory did not threaten competition in the pathology services market.
An announcement made last Thursday of a realignment in priority drug research projects prompted Citi analyst to advise shareholders of a possible interest divestment in diabetes drug joint venture between Bristol-Myers Squibb and AstraZeneca.
